Found: 137
Select item for more details and to access through your institution.
Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 4, p. 471, doi. 10.1007/s40256-020-00447-5
- By:
- Publication type:
- Article
Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 21, p. 2497, doi. 10.1001/jama.298.21.2497
- By:
- Publication type:
- Article
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 17, p. 1883, doi. 10.1001/jama.297.17.1883
- By:
- Publication type:
- Article
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein llb/llla Inhibitors in Acute Coronary Syndromes.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 6, p. 591, doi. 10.1001/jama.297.6.591
- By:
- Publication type:
- Article
Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 10, p. 1152, doi. 10.1001/jama.295.10.1152
- By:
- Publication type:
- Article
When (Not) to Stop a Clinical Trial for Benefit.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Editorial.
- Published in:
- Human & Experimental Toxicology, 1985, v. 4, n. 5, p. 471, doi. 10.1177/096032718500400501
- By:
- Publication type:
- Article
Reporting noninferiority trials--reply.
- Published in:
- 2013
- By:
- Publication type:
- letter
Reporting Noninferiority Trials.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Reporting of Noninferiority and Equivalence Randomized Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 24, p. 2594, doi. 10.1001/jama.2012.87802
- By:
- Publication type:
- Article
Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Dexmedetomidine vs Midazolam or Propofol for Sedation During Prolonged Mechanical Ventilation.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 11, p. 1151, doi. 10.1001/jama.2012.304
- By:
- Publication type:
- Article
Current controversies in data monitoring for clinical trials.
- Published in:
- Clinical Trials, 2006, v. 3, n. 6, p. 513, doi. 10.1177/1740774506073467
- By:
- Publication type:
- Article
STROBE Statement: linee guida per descrivere gli studi osservazionali. Traduzione italiana.
- Published in:
- Medici Oggi, 2022, p. 1
- By:
- Publication type:
- Article
Group sequential methods in the design and analysis of clinical trials.
- Published in:
- Biometrika, 1977, v. 64, n. 2, p. 191
- By:
- Publication type:
- Article
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
- Published in:
- Bulletin of the World Health Organization, 2007, v. 85, n. 11, p. 867, doi. 10.2471/BLT.07.045120
- By:
- Publication type:
- Article
Ordered Polytomous Regression: An Example Relating Serum Biochemistry and Haematology to Alcohol Consumption.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1986, v. 35, n. 3, p. 289, doi. 10.2307/2348029
- By:
- Publication type:
- Article
Regression Models and Non-proportional Hazards in the Analysis of Breast Cancer Survival.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1984, v. 33, n. 2, p. 176, doi. 10.2307/2347444
- By:
- Publication type:
- Article
Regression of Area Mortality Rates on Expalanatory Variables: What Weighting is Appropriate?
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1981, v. 30, n. 3, p. 286, doi. 10.2307/2346353
- By:
- Publication type:
- Article
Management of acute coronary syndrome and the importance of hospital access: findings from the EPICOR Asia study.
- Published in:
- European Journal of Cardiovascular Medicine, 2017, v. 5, n. 2, p. 522, doi. 10.5083/ejcm.20424884.150
- By:
- Publication type:
- Article
Management of acute coronary syndrome and the importance of hospital access: findings from the EPICOR Asia study.
- Published in:
- European Journal of Cardiovascular Medicine, 2016, v. 4, n. 1, p. 522, doi. 10.5083/ejcm.20424884.150
- By:
- Publication type:
- Article
Ever-Pregnant Female Blood Donors and Mortality Risk in Male Recipients.
- Published in:
- 2018
- By:
- Publication type:
- letter
State of the art in comparative cancer clinical trials.
- Published in:
- Cancer (0008543X), 1987, v. 60, n. 11, p. 2811, doi. 10.1002/1097-0142(19871201)60:11<2811::AID-CNCR2820601136>3.0.CO;2-P
- By:
- Publication type:
- Article
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard.
- Published in:
- 1976
- By:
- Publication type:
- journal article
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Blood pressure reduction and anti‐hypertensive treatment choice: A post‐hoc analysis of the SPRINT trial.
- Published in:
- Clinical Cardiology, 2021, v. 44, n. 5, p. 665, doi. 10.1002/clc.23591
- By:
- Publication type:
- Article
Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 12, p. 1352, doi. 10.1002/clc.23476
- By:
- Publication type:
- Article
Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 9, p. 999, doi. 10.1002/clc.23400
- By:
- Publication type:
- Article
Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 4, p. 346, doi. 10.1002/clc.23322
- By:
- Publication type:
- Article
Predicting risk of cardiovascular events 1 to 3 years post‐myocardial infarction using a global registry.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 1, p. 24, doi. 10.1002/clc.23283
- By:
- Publication type:
- Article
Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 1, p. 111, doi. 10.1002/clc.23116
- By:
- Publication type:
- Article
Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 12, p. 1197, doi. 10.1002/clc.22837
- By:
- Publication type:
- Article
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration.
- Published in:
- Annals of Internal Medicine, 2007, v. 147, n. 8, p. W163, doi. 10.7326/0003-4819-147-8-200710160-00010-w1
- By:
- Publication type:
- Article
The Strengthening the Reporting of Observational Studies in Epidemiology(STROBE) Statement: Guidelines for Reporting Observational Studies.
- Published in:
- Annals of Internal Medicine, 2007, v. 147, n. 8, p. 573
- By:
- Publication type:
- Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 396, doi. 10.1093/eurheartj/ehac693
- By:
- Publication type:
- Article
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 4991, doi. 10.1093/eurheartj/ehac495
- By:
- Publication type:
- Article
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3435, doi. 10.1093/eurheartj/ehac320
- By:
- Publication type:
- Article
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2984, doi. 10.1093/eurheartj/ehac306
- By:
- Publication type:
- Article
Incremental value of C‐reactive protein to the MEESSI acute heart failure risk score.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1749, doi. 10.1002/ejhf.3349
- By:
- Publication type:
- Article
Insulin‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 806, doi. 10.1002/ejhf.3227
- By:
- Publication type:
- Article
Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 900, doi. 10.1002/ejhf.3221
- By:
- Publication type:
- Article
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR‐Preserved analysis.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 952, doi. 10.1002/ejhf.3180
- By:
- Publication type:
- Article
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 788, doi. 10.1002/ejhf.3166
- By:
- Publication type:
- Article
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Preserved.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 885, doi. 10.1002/ejhf.3136
- By:
- Publication type:
- Article
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 274, doi. 10.1002/ejhf.3101
- By:
- Publication type:
- Article
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 155, doi. 10.1002/ejhf.3078
- By:
- Publication type:
- Article
Health status across major subgroups of patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1623, doi. 10.1002/ejhf.2831
- By:
- Publication type:
- Article